Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving leading biopharmaceutical companies globally:

McKesson
Express Scripts
Medtronic
AstraZeneca
Johnson and Johnson
Harvard Business School

Last Updated: November 22, 2019

DrugPatentWatch Database Preview

Drugs in Development Information for Oxamic Acid

See Plans and Pricing

« Back to Dashboard

What is the drug development status for Oxamic Acid?

Oxamic Acid is an investigational drug.

There have been 130 clinical trials for Oxamic Acid. The most recent clinical trial was a Phase 2 trial, which was initiated on February 1st 2013.

The most common disease conditions in clinical trials are Lymphoma, Leukemia, and Precursor Cell Lymphoblastic Leukemia-Lymphoma. The leading clinical trial sponsors are National Cancer Institute (NCI), Merck Sharp & Dohme Corp., and M.D. Anderson Cancer Center.

There is one US patent protecting this investigational drug and eight international patents.

Recent Clinical Trials for Oxamic Acid
TitleSponsorPhase
Topical Remetinostat Gel as Neoadjuvant Therapy in Patients With Squamous Cell Carcinoma (SCC)Kavita SarinPhase 2
Olaparib in Combination With Vorinostat in Patients With Relapsed/Refractory and/or Metastatic Breast CancerAstraZenecaPhase 1
Olaparib in Combination With Vorinostat in Patients With Relapsed/Refractory and/or Metastatic Breast CancerJenny C. Chang, MDPhase 1

See all Oxamic Acid clinical trials

Clinical Trial Summary for Oxamic Acid

Top disease conditions for Oxamic Acid
Top clinical trial sponsors for Oxamic Acid

See all Oxamic Acid clinical trials

US Patents for Oxamic Acid

Drugname Patent Number Patent Title Patent Assignee Estimated Expiration
Oxamic Acid   Start Trial Process for the preparation of oxalyl- and oxamyl-hydrazides Enichim ANIC S.p.A. (Palermo, IT)   Start Trial
Oxamic Acid   Start Trial Novel fluorinated resorcinol ethers and their use as anti-allergics and anti-inflammatories Ciba-Geigy Corporation (Ardsley, NY)   Start Trial
Oxamic Acid   Start Trial Simultaneous assay for glucose and urea Abbott Laboratories (Abbott Park, IL)   Start Trial
Oxamic Acid   Start Trial N-acetylmannosamine dehydrogenase, process for its production, method for quantitatively analyzing N-acetylmannosamine or sialic acid, and kit for the quantitative analysis Noda Institute for Scientific Research (Noda, JP)   Start Trial
Oxamic Acid   Start Trial N,N'-hydrocarbylenebis[N-hals-substituted amic acid hydrazides] and their derivatives Atochem North America, Inc. (Philadelphia, PA)   Start Trial
Oxamic Acid   Start Trial Novel oxamic acid compounds and pharmaceutical composition for use in improvement of damaged cerebral functions of brain Meiji Seika Kaisha, Ltd. (JP)   Start Trial
>Drugname >Patent Number >Patent Title >Patent Assignee >Estimated Expiration

International Patents for Oxamic Acid

Drugname Country Document Number Estimated Expiration Related US Patent
Oxamic Acid Austria 78246 2008-04-21   Start Trial
Oxamic Acid Germany 68902078 2008-04-21   Start Trial
Oxamic Acid European Patent Office 0338387 2008-04-21   Start Trial
Oxamic Acid Spain 2042850 2008-04-21   Start Trial
Oxamic Acid Greece 3005201 2008-04-21   Start Trial
Oxamic Acid Italy 1218223 2008-04-21   Start Trial
>Drugname >Country >Document Number >Estimated Expiration >Related US Patent

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Colorcon
Boehringer Ingelheim
Johnson and Johnson
AstraZeneca
McKinsey
McKesson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.